Actively Recruiting
TCM as an Adjuvant Treatment in Breast Cancer Patients
Led by Universiti Tunku Abdul Rahman · Updated on 2024-12-31
30
Participants Needed
1
Research Sites
136 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Chinese herbs can alleviates the side effects caused by conventional treatment in breast cancer patients and affects the syndrome element differentiation by altering the specific set of proteomes at specific time point of treatment.
CONDITIONS
Official Title
TCM as an Adjuvant Treatment in Breast Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Postmenopausal women as determined by cessation of menses for at least 1 year or FSH >20 mIU/mL
- Histology confirmed stage 2 to 3 hormone-receptor positive breast cancer patient
- Currently taking letrozole for at least 1 month
- Reported ongoing musculoskeletal pain or stiffness, which started or worsened after initiation of letrozole
- Had a baseline average pain score over the past week on the Brief Pain Inventory Short Form (BPI-SF) of 54 points on a scale of 0 to 10
- Completed all indicated surgery, chemotherapy and radiation therapy
- Agreed to take prescribed Chinese herbs
- No evidence of distant metastasis
- Follow-up for the duration of the study
- No acute disease in the past month
- Able to communicate to practitioner and interviewer
- Willing to give informed consent
You will not qualify if you...
- Pregnant or nursing woman or woman of childbearing potential without effective method of birth control
- Patients who default subsequent follow-up or have irregular follow-up
- Patients involved in other studies at the same time
- History of non-compliance to medical regimen or unwilling/unable to comply with protocol
- Bedridden and/or cancer metastasis to bone or lung
- Concurrent infection requiring intravenous antibiotics
- History of allergy to Chinese herbs
- Previously received Chinese herbs for AI-induced musculoskeletal symptoms
- Received Chinese herbs within one month prior to study entry
- Current use of steroids or narcotics for pain relief within the past 2 weeks
- Acute onset of chronic illness or acute disease in the past month or pre-existing chronic diseases
- Patients with severe illness or metastatic disease such as poorly controlled hypertension, hypothyroidism, diabetes mellitus, liver diseases, osteoarthritis, rheumatoid arthritis, gout or neuropathic arthropathy, autoimmune or inflammatory joint disease, bone fracture, stroke
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Tung Shin Hospital
Bukit Bintang, Kuala Lumpur, Malaysia, 55100
Actively Recruiting
Research Team
C
Chin Long Poo
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here